Advisors Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Advisors Capital Management's ATRC Position: Q2 2026 in Review
Advisors Capital Management reduced its AtriCure (ATRC) stake by 4.3% in Q2 2026, selling an estimated $220K and leaving 174,496 shares worth $4.88M. The position accounts for 0.05% of the portfolio, ranked #220.
Advisors Capital Management first reported a position in ATRC in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.23M in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Advisors Capital Management held 174,496 shares of AtriCure worth $4.88M as of Q2 2026.
- Advisors Capital Management sold 7,818 AtriCure shares in Q2 2026, an estimated $220K.
- AtriCure made up 0.05% of Advisors Capital Management's portfolio in Q2 2026, its #220 holding.
- Advisors Capital Management first reported a position in AtriCure in Q1 2021 and has held it in 22 quarters since.
- Advisors Capital Management's AtriCure position peaked at $7.23M in Q4 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.